If you are searching for compounded semaglutide in Prague, or wondering which Czech pharmacy will make up the version you were getting in the United States, the answer is short and it is not a matter of finding the right supplier. The category does not exist here. There is no legal Czech market for pharmacy-made copies of these medicines, no pharmacy chain quietly doing it, and no clinic that can arrange it.

That is worth understanding rather than working around, because the sites that will happily sell you "compounded semaglutide" delivered to a Czech address are not a cheaper version of the US system. They are something else entirely, and regulators have been specific about what tends to be inside the box.

What "compounded" meant in the United States

Compounding is a real and long-standing pharmacy practice: a pharmacy prepares a medicine for an individual patient rather than dispensing a mass-produced pack. Every developed pharmaceutical system has some version of it, Czechia included. What made compounded semaglutide unusual was its scale.

Semaglutide injection products were in shortage in the US from 2022 as demand climbed. Under US rules, a drug being on the FDA shortage list opens a specific compounding pathway, and pharmacies and outsourcing facilities began preparing semaglutide at volume. An entire telehealth pricing tier grew up around it: monthly programmes noticeably cheaper than the branded products, marketed hard, and available without insurance.

Then the shortage ended. On 21 February 2025 the FDA determined that the semaglutide injection shortage was resolved, and set out the wind-down: state-licensed pharmacies had until 22 April 2025, and outsourcing facilities until 22 May 2025, to stop compounding products that are essentially copies of the approved medicine (FDA). Litigation followed, and the courts declined to suspend those deadlines. At the time of writing, the FDA's own guidance records that semaglutide and tirzepatide sit neither on its shortage list nor on the list of substances outsourcing facilities may compound from in bulk.

The mass-market category is therefore gone in the US too. What remains is narrower: compounding for an identified individual patient, on a prescription, where a prescriber has documented that the product contains a change producing a significant difference from the commercially available medicine for that specific person. This is the legal seam that "personalised" and "custom dose" offerings sit in, and the FDA has said plainly that adding something like vitamin B12 does not by itself take a product out of the essentially-a-copy category. The manufacturer of the branded products has also brought a large volume of civil litigation in US courts against sellers of compounded copies. None of that is settled ground.

We mention all of this for one reason: if you arrived in Czechia expecting the US market of 2023 to still be there, it is not there in the United States either. Our overview of what happens when you move is in what US weight-loss telehealth users should know in Czechia.

Why the category does not exist in Czechia or the EU

The US path depended on a shortage exemption in US law. There is no equivalent construction in EU or Czech pharmaceutical law, and the underlying principle runs the other way.

Pharmacy preparation here is an exception, tightly scoped to an individual patient and an individual prescription. It is not a parallel supply route, and it is not a way of producing cheaper versions of medicines that already hold a marketing authorisation. Where an authorised medicinal product is available, that is what is used. Czech regulator SÚKL has stated the principle directly: medicines prepared in a pharmacy cannot be considered identical to registered, industrially manufactured medicines, and even where the same active substance appears at the same concentration in the same pharmaceutical form, such a product is not interchangeable with the registered one. Industrial manufacturing and pharmacy preparation are different activities under different rules (SÚKL, in Czech).

There is a practical dimension underneath the legal one. Semaglutide is a peptide in a sterile injectable formulation, delivered from a device with a defined dose mechanism. That is an industrial manufacturing problem involving sterility assurance, stability data and device engineering, not something a dispensing pharmacy is set up to reproduce.

So the honest summary is not "it is hard to find in Czechia". It is that there is nothing legitimate to find. Anything offered to a Czech address under that name comes from outside the regulated supply chain.

What "compounded semaglutide online" actually means from Czechia

Once you accept that no licensed Czech pharmacy supplies it, the question becomes what the websites are actually shipping. Regulators have answered this repeatedly, and the answer is not reassuring.

In September 2025 the European Medicines Agency and the Heads of Medicines Agencies issued a joint warning about a sharp rise in illegal medicines sold in the EU, singling out products marketed as GLP-1 receptor agonists including semaglutide, liraglutide and tirzepatide. Their assessment of what these products contain was blunt: they "may not contain the claimed active substance at all and may contain harmful levels of other substances", leaving users at high risk of treatment failure, serious health problems and dangerous interactions (EMA). The same warning notes that authorised online retailers in the EU display a common logo linking to a national register; a site without it is operating illegally.

This is not theoretical. In October 2023 the EMA alerted patients and healthcare professionals to falsified pens found at wholesalers in Austria and Germany, exposed by serial numbers registering as inactive in the EU verification system. The Austrian regulator reported patients treated in hospital after using suspected counterfeit product, with hypoglycaemia and seizures pointing to insulin in place of semaglutide. In someone without diabetes, that is a threat to life.

Add the things you do not get from an unregulated seller: no batch traceability, no recall notice if something is withdrawn, no cold chain you can verify, no prescriber supervising your dose, and no one to tell an emergency doctor what you actually injected. Our article on illegal online pharmacies targeting Czechia goes through the warning signs in detail, including the Czech mechanism under which internet providers must block listed illegal sites.

One further point specific to Czechia. Even for genuine, authorised medicine, mail order of prescription medicines is illegal here. Distance selling by pharmacies covers non-prescription products only, so any site offering to post a prescription injection to your address in Prague or Brno has identified itself before you have read a word of its product page.

What is actually available in Czechia

The alternative is not worse care. It is the ordinary European route.

Several GLP-1 medicines hold a marketing authorisation and are supplied in Czechia, each with an approved indication, an approved dose schedule, a summary of product characteristics and a traceable supply chain. They are all prescription-only. What each one is approved to treat, and why two products containing the same substance are not interchangeable, is set out in our comparison of GLP-1 medicines registered in Czechia. Whether a specific strength is currently being supplied is a separate question from whether it is authorised, and the current national picture is in our note on availability in Czech pharmacies.

The pathway is straightforward. A doctor licensed in Czechia assesses you: your history, your measurements, your other medicines, what you have taken before and how you tolerated it. A doctor always makes the decision, and the doctor may adjust the plan, request laboratory tests first, or decline treatment. That is a real possible outcome. If treatment is judged appropriate, the doctor issues a Czech eRecept, and you collect the medicine yourself at any pharmacy in the country. GoOn is paid for consultations; the medicine is dispensed and paid for at the pharmacy. Our guide to the Czech eRecept system explains how that works if you have no Czech insurance number, and consultations can be held in English.

If you were previously on a compounded product, bring what documentation you have. The substance, the concentration and your actual dose history matter far more to a Czech doctor than the marketing name of the tier you were on, and a compounded dose will not always correspond neatly to an approved dose step. The practicalities of continuing care after a move are covered in continuing GLP-1 treatment after moving to Czechia.

Frequently asked questions

Can a Czech pharmacy compound semaglutide for me?

No. Pharmacy preparation in Czechia is an exception for an individual patient, not a route for producing copies of medicines that already hold a marketing authorisation. SÚKL has stated that a pharmacy-prepared product cannot be considered identical or interchangeable with a registered industrially manufactured one, and semaglutide is in any case a sterile injectable peptide delivered from a manufactured device.

Is compounded semaglutide legal anywhere in the EU?

There is no legal retail market for compounded copies of authorised GLP-1 medicines in the EU. The US shortage-based pathway that produced the category has no equivalent under EU and Czech pharmaceutical law, and it has itself narrowed sharply in the United States since the FDA declared the semaglutide shortage resolved in February 2025.

What about sites that ship "compounded semaglutide" to the Czech Republic?

Those are unregulated imports of unknown provenance. The EMA and the Heads of Medicines Agencies warned in September 2025 about a sharp rise in illegal products marketed as GLP-1 medicines, which may contain none of the claimed active substance and may contain harmful levels of other substances. Separately, mail order of prescription medicines is illegal in Czechia, so the delivery offer alone marks the seller as operating outside the law.

I was on a compounded microdose in the US. Can I continue it here?

Not as the same product. A Czech doctor works with authorised medicines at their approved dose steps, so continuing may mean moving to a standard titration schedule rather than resuming an exact custom dose. Bring your records, including substance, concentration and dates, and discuss it at the consultation.

Is the branded medicine covered by Czech health insurance?

Not for weight management. Public health insurance does not reimburse these medicines for this purpose, so treatment is self-pay for Czech citizens and foreign residents alike, at the same price. Commercial policies sold to foreign nationals are generally built to match the scope of public insurance, so they usually do not pay either.